Jury Rules In Favour of AstraZeneca in First US Seroquel Product Liability Trial
- Details
- Category: AstraZeneca

Roche uniquely positioned to deliver long-term growth
- Details
- Category: Roche

New PLATO Sub-Analysis of CABG Patients Presented at ACC
- Details
- Category: AstraZeneca

Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
- Details
- Category: Abbott

Pfizer Discontinues A Phase 3 Study Of Figitumumab
- Details
- Category: Pfizer

Sanofi-aventis Successfully Completes the Acquisition of Chattem, Inc.
- Details
- Category: Sanofi

Roche and Biogen Idec decide to suspend Ocrelizumab treatment
- Details
- Category: Roche

More Pharma News ...
- Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
- Novel Drug for Chronic Management of Hyperuricemia in Gout Patients
- Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus
- Lundbeck delivers 22 percent revenue growth for 2009
- Bristol-Myers Squibb and Allergan Enter Global Agreement
- Anavex comments on failure of Pfizer and Medivation's Alzheimer's Investigational drug Dimebon
- Pfizer and Medivation Announce Results From Two Phase 3 Studies in Dimebon